Pterostilbene Enhances Cytotoxicity and Chemosensitivity in Human Pancreatic Cancer Cells

Gemcitabine (GEM) drug resistance causes high mortality rates and poor outcomes in pancreatic ductal adenocarcinoma (PDAC) patients. Receptor for advanced glycation end products (RAGE) involvement in the GEM resistance process has been demonstrated. Therefore, finding a safe and effective way to inh...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Yi-Hao, Chen, Sheng-Yi, Wang, Sheng-Yang, Lin, Jer-An, Yen, Gow-Chin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281188/
https://www.ncbi.nlm.nih.gov/pubmed/32375296
http://dx.doi.org/10.3390/biom10050709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7281188/
https://www.ncbi.nlm.nih.gov/pubmed/32375296
http://dx.doi.org/10.3390/biom10050709

Ejemplares similares